In subjects with elevated cardiovascular disease (CVD) risk, MRT-8102, a NEK7-directed molecular glue degrader in development for the treatment of NLRP3/IL-1/IL-6 driven inflammatory diseases, ...
Stocktwits on MSN
Why did GLUE stock surge over 50% in premarket today?
CRP levels below 2 mg/L, a threshold associated with lower cardiovascular risk. ・Safety data were favorable, with adverse ...
Clinical-stage biotechnology company Monte Rosa Therapeutics Inc. (NASDAQ: GLUE) on Wednesday revealed interim data from an ...
Monte Rosa shares surge 45% after interim phase I data show that MRT-8102 drives deep NEK7 degradation and reduces sharp inflammation markers.
New research highlights C-reactive protein as a stronger heart disease predictor than cholesterol. This shift may change how heart risks are assessed and managed in India.
A rare condition called Eosinophilic Fasciitis caused a 42-year-old engineer severe pain and stiffness. Doctors identified ...
Part of the challenge lies with identifying otherwise healthy individuals — especially women — who lack standard modifiable ...
Key Takeaways Strong heart health means your heart and blood vessels, aka your cardiovascular system, are working efficiently ...
Verywell Health on MSN
What Happens When You Take Magnesium and Probiotics Together?
Taking probiotics and magnesium together is considered safe and may help with mood and the gut microbiome. It's not ...
Investing.com -- Monte Rosa Therapeutics (NASDAQ:GLUE) stock surged 13% after the company reported positive interim Phase 1 data for its MRT-8102 drug, demonstrating significant reductions in ...
A simple blood test can tell doctors when it is safe to stop antibiotics in patients recovering from sepsis, a review led by ...
Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and immune system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback